Brief Reports
Copyright ©The Author(s) 2004.
World J Gastroenterol. Apr 15, 2004; 10(8): 1212-1214
Published online Apr 15, 2004. doi: 10.3748/wjg.v10.i8.1212
Table 1 Patients characteristics
Group A With ESGroup B w/o ESTotal
Patients9696192
Median Age (± SD)72 ± 675 ± 673 ± 7
Gender (M/F)51/3547/3998/74
Bilirubine (mg/dL)13.511.912.7
Stent lenght(cm)6.786.766.79
Visualization of pancreatic duct7779156
Pancreatic cancer64 (66.6 %)67 (69.8 %)131 (68.2%)
Cholangiocarcinoma31 (32.3 %)28 (29.1 %)59 (30.7 %)
Metastatic lymph nodes1 (1.1%)1 (1.1%)2 (1.1 %)
Table 2 Endoscopic tecnique results
Group A With ES (%)Group B w/o ES (%)P
Successful stent insertion92/96 (95.8)90/96 (93.7)0.745
Early complications6/92 (6.5)4/90 (4.4)0.772
Pancreatitis2/92 (2.2)2/90 (2.2)0.629
Bleeding3/92 (3.7)0/900.252
Clogging1/92 (1.2)2/900.985
Procedure related mortality00
Late complications16/92 (17.4)15/90 (16.6)0.946
Migration3/92 (3.2)3/90 (3.3)0.698
Table 3 Stents replacement
Group A with ESGroup B w/o ESP
Patients (n)4146
Successful stent replacement39/4145/460.919
Patency (median ± SD)109 ± 15110 ± 180.765